Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

SELL
$59.26 - $71.14 $5,807 - $6,971
-98 Reduced 9.32%
953 $63,000
Q1 2022

May 11, 2022

SELL
$55.72 - $67.12 $159,916 - $192,634
-2,870 Reduced 73.2%
1,051 $70,000
Q4 2021

Jan 10, 2022

SELL
$54.02 - $63.83 $33,654 - $39,766
-623 Reduced 13.71%
3,921 $228,000
Q3 2021

Nov 24, 2021

BUY
$55.56 - $60.79 $23,501 - $25,714
423 Added 10.26%
4,544 $273,000
Q2 2021

Jul 30, 2021

BUY
$48.42 - $60.18 $40,721 - $50,611
841 Added 25.64%
4,121 $247,000
Q1 2021

Apr 29, 2021

SELL
$47.16 - $54.44 $2,027 - $2,340
-43 Reduced 1.29%
3,280 $163,000
Q4 2020

Jan 15, 2021

BUY
$48.52 - $58.02 $121,202 - $144,933
2,498 Added 302.79%
3,323 $166,000
Q3 2020

Oct 21, 2020

SELL
$53.07 - $61.1 $2,069 - $2,382
-39 Reduced 4.51%
825 $45,000
Q2 2020

Jul 10, 2020

BUY
$43.1 - $55.31 $13,231 - $16,980
307 Added 55.12%
864 $46,000
Q1 2020

Apr 15, 2020

BUY
$37.79 - $51.33 $14,549 - $19,762
385 Added 223.84%
557 $25,000
Q4 2019

Jan 22, 2020

SELL
$42.46 - $50.46 $551 - $655
-13 Reduced 7.03%
172 $9,000
Q3 2019

Oct 25, 2019

BUY
$40.12 - $45.47 $722 - $818
18 Added 10.78%
185 $8,000
Q2 2019

Aug 07, 2019

SELL
$37.28 - $41.68 $111 - $125
-3 Reduced 1.76%
167 $7,000
Q1 2019

Apr 29, 2019

BUY
$35.49 - $43.02 $6,033 - $7,313
170 New
170 $7,000
Q4 2018

Feb 04, 2019

BUY
$36.86 - $41.49 $0 - $0
0 New
0 $0
Q2 2018

Aug 14, 2018

SELL
$34.55 - $37.05 $4,042 - $4,334
-117 Closed
0 $0
Q3 2017

Oct 26, 2017

BUY
$28.96 - $34.0 $608 - $714
21 Added 21.88%
117 $4,000
Q2 2017

Aug 08, 2017

BUY
N/A
96
96 $3,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $220B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.